Seronegative rheumatoid arthritis after combination therapy with ipilimumab and nivolumab for postoperative pancreatic and liver metastases from renal cell carcinoma

Introduction Since the approval of immune checkpoint inhibitors for renal cell carcinoma treatment, therapeutic efficacy has been enhanced. However, although autoimmune‐related side effects may occur, rheumatoid immune‐related adverse events seldom develop. Case presentation A 78‐year‐old Japanese m...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yuki Nishimura, Kazuaki Yamanaka, Taigo Kato, Koji Hatano, Atsunari Kawashima, Shinichiro Fukuhara, Motohide Uemura, Ryoichi Imamura, Norio Nonomura
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2023-03-01
coleção:	IJU Case Reports
Assuntos:	immune‐related adverse event ipilimumab nivolumab renal cell carcinoma seronegative rheumatoid arthritis
Acesso em linha:	https://doi.org/10.1002/iju5.12560
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!